Molecular Formula | C16H20N2O2 |
Molar Mass | 272.34 |
Density | 1.137±0.06 g/cm3(Predicted) |
Boling Point | 468.4±45.0 °C(Predicted) |
pKa | 10.05±0.40(Predicted) |
Storage Condition | 2-8°C |
In vitro study | ST271 partially inhibits peptide phosphorylation in the membrane preparation and in permeabilized platelets. ST271 (100 μM) causes complete inhibition of formation of inositol phosphates induced by FcγRII cross-linking, but also induces a small (< 30%) but significant inhibition of the response to thrombin and U46619. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.672 ml | 18.359 ml | 36.719 ml |
5 mM | 0.734 ml | 3.672 ml | 7.344 ml |
10 mM | 0.367 ml | 1.836 ml | 3.672 ml |
5 mM | 0.073 ml | 0.367 ml | 0.734 ml |
biological activity | ST271 is a tyrosine phosphorylation inhibitor that inhibits phospholipase D activity. |
target | TargetValue PLD () |
Target | Value |
in vitro study | ST271 partially inhibits peptide phosphorylation in the membrane preparation and in permeabilized platelets. ST271 (100 μ m) results complete inhibition of formation of inositol phosphates induced by FcγRII cross-linking, but also induces a small (< 30%) but significant inhibition of the response to thrombin and U46619. |